-
1 Comment
Shanghai Rongtai Health Technology Corporation Limited is currently in a long term uptrend where the price is trading 17.2% above its 200 day moving average.
From a valuation standpoint, the stock is 59.2% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 2.1.
Shanghai Rongtai Health Technology Corporation Limited's total revenue sank by 1.0% to $526M since the same quarter in the previous year.
Its net income has dropped by 15.9% to $61M since the same quarter in the previous year.
Finally, its free cash flow grew by 323.4% to $106M since the same quarter in the previous year.
Based on the above factors, Shanghai Rongtai Health Technology Corporation Limited gets an overall score of 3/5.
Exchange | SHG |
---|---|
CurrencyCode | CNY |
Sector | Consumer Cyclical |
Industry | Leisure |
ISIN | CNE100002R81 |
Market Cap | 5B |
---|---|
PE Ratio | 29.58 |
Target Price | 15.6 |
Beta | 0.7 |
Dividend Yield | None |
Shanghai Rongtai Health Technology Corporation Limited, together with its subsidiaries, engages in the design, research, development, production, and sale of massage appliances under the Rongtai and Momoda brands in China and internationally. The company offers massage chairs and its accessories, neck massagers, eye massagers, massage backrests, massage belts, foot massagers, massage cushions, and hand-held massagers, etc. It also provides massage services. The company sells its products through direct sales, e-commerce, sales counters in chain stores and department stores, and distributors, as well as exports its products. It is also involved in the software, financial, and application service industries; and investing activities. Shanghai Rongtai Health Technology Corporation Limited was founded in 1997 and is based in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603579.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025